COVID-19 vaccine vaccination rate has exceeded 64%

Kwon Joon-wook, the 2nd vice-president of the Central Disease Control Headquarters, said, "We plan to discard 770 doses due to carelessness in medical institutions."

Quarantine authorities are in negotiations with Moderna and Janssen ahead of the second quarter

COVID-19 vaccine vaccination rate has exceeded 60%.

 

As the AstraZeneca vaccine is recommended for those over 65 years of age, the quarantine authorities decided to introduce an additional 7 million doses (for 3.5 million people) from the end of May.

 

Joon-wook Kwon, the 2nd vice-president of Central Disease Control Headquarters, explained this trend through a regular briefing of COVID-19 Central Disease Control Headquarters during the day (11th).

 

According to him, as of today's 0 o'clock, an additional 51,100 new people were vaccinated, and the first dose of COVID-19 vaccine was completed for 500,635 people, and the inoculation rate reached 64%.

 

By vaccination institution and target audience, 175,454 people (85.9%) in nursing hospitals, 75,690 people (69.7%) in nursing facilities, 27,226 people (36%) in the first responder, and 209,334 (62.3%) in medical institutions and above, and 12,931 (22.7%) people were vaccinated in COVID-19 patient treatment hospital.

 

Looking at the current status of COVID-19 treatment administration, the treatment 'Veklury (Remdesivir)' was administered to 4,975 patients in 122 hospitals as of 0 o'clock on the 10th.

 

COVID-19 antibody treatment 'Regkirona (Regdanvimab)' was administered to 381 patients in 44 hospitals based on the same criteria.

 

The vaccination promotion team announced that it will introduce 7 million doses (for 3.5 million people) of AstraZeneca vaccine from the last week of May to the end of June.

 

This is the amount of individual contracts that will be introduced as the second, following 1.57 million doses of this product, which was first introduced from February 24th to 27th.

 

The quarantine authorities are continuing to negotiate with pharmaceutical companies to secure quantities of Moderna and Janssen products that will be used for vaccination starting in the second quarter.

 

He said that in medical institutions such as nursing homes and hospitals, there were cases in which the vaccine could not be used due to an accidental deviation in the temperature of the vaccine due to problems such as negligence during the storage of the vaccine.

 

He said, “Due to a breakdown in the refrigerator, an abnormal thermometer, and carelessness of the person in charge of vaccine management, 770 doses of vaccines have been suspended at 7 medical institutions so far.

 

We will continue to strengthen the supervision of consignment medical institutions in cooperation with local governments and the Ministry of the Interior and Safety.” He added, “Please keep and manage the vaccine thoroughly so that it does not happen that the vaccine is discarded due to minor carelessness even at the consignment medical institution.”